IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q4 2022 Holdings

Filed 2023-02-13 | 10 holdings | $230.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Karuna Therapeutics IncCOM48576A100$150.5M765,89565.4%
Vaxcyte Inc(PCVX)COM92243G108$33.2M693,03914.5%
Rallybio CorpCOM75120L100$15.8M2,404,6446.9%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$8.4M569,0413.7%
Vigil Neuroscience Inc(VIGL)COM92673K108$7.0M560,5953.0%
Fusion Pharmaceuticals IncCOM36118A100$4.9M1,560,9842.1%
Exscientia PLCADS30223G102$4.1M772,2851.8%
Inozyme Pharma IncCOM45790W108$2.8M2,661,1541.2%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$2.5M1,891,4671.1%
Aligos Therapeutics IncCOM01626L105$708.3K743,2150.3%